WAT
Waters Corporation
Is WAT Halal?
Analytical instruments are generally permissible, subject to acquisition and end-use review.
What You Should Know
Waters's April 4, 2026 filing shows debt/assets of 21.26%, liquidity/assets of 1.88%, receivables plus cash/assets of 9.03% and disclosed interest income/revenue of 0.47%. Chromatography, mass spectrometry, laboratory software and services are generally permissible, while pharmaceutical, food, environmental and industrial end uses—and the BDS acquisition—remain qualitative topics.
⚠️ Concerns
- •The BDS acquisition materially changed debt, goodwill, intangibles and customer exposure
- •Analytical tools serve pharmaceutical and laboratory workflows requiring product and research review
- •Customer end-use revenue is not allocated into a universal prohibited-activity numerator
- •Financial ratios pass the examined asset-based screens, but business classification remains incomplete
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-04-04; calculated 2026-07-14.
5,215 / 24,531
462 / 24,531
2,215 / 24,531
6 / 1,267
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 21.26%, liquidity/assets is 1.88%, receivables plus cash/assets is 9.03% and interest income/revenue is 0.47%, below the examined limits; business classification remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 21.26%, liquidity/assets is 1.88% and receivables plus cash/assets is 9.03%, below the examined MSCI total-assets limits; activity classification remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
The examined ratios pass at debt/assets 21.26% and liquidity/assets 1.88%; activity classification remains incomplete and this is not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A licensed historical market-cap series is not stored and business classification remains incomplete, so market-cap methods are not estimated from a current spot price.
Business-activity disclosure
Waters makes analytical instruments, chromatography and mass-spectrometry systems, laboratory software and service offerings used in life-science, pharmaceutical, food, environmental and industrial analysis. The core measurement activity is generally permissible, while customer end uses, regulated workflows and the BDS acquisition require continuing review.
Limitation: The filing does not allocate revenue into a universal prohibited-activity numerator for pharmaceutical, food, environmental, industrial or government end uses, and it does not classify acquired BDS revenue by a Sharia taxonomy.
Purification
Waters discloses $6 million of interest income but does not prescribe a scholar-approved purification percentage; the disclosed ratio is evidence for the income screen, not a complete purification prescription.
Inputs, assumptions and primary sources
- Amounts are USD millions from Waters's April 4, 2026 Form 10-Q and rounded to the nearest million.
- Debt includes $360 million of notes payable and $4,855 million of long-term debt; operating leases are excluded.
- Cash and cash equivalents are $462 million; no separately identified interest-bearing securities balance is added.
- Accounts receivable, net are $1,753 million and first-quarter total revenue is $1,267 million; disclosed interest income is $6 million.
- Waters acquired the BDS business during the quarter; the resulting debt, goodwill and intangible balances are included in the reported totals.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →